A Comparison Study With Alendronate and Raloxifene in Postmenopausal Women With Osteoporosis (0217-189)
Condition: Osteoporosis, PostmenopausalInterventions: Drug: MK0217, /Duration of Treatment : 12 Months; Drug: Comparator : raloxifene hydrochloride /Duration of Treatment : 12 MonthsSponsor: Merck Sharp & Dohme Corp.Completed - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2006 Category: Research Source Type: clinical trials
Raloxifene for Women With Alzheimer's Disease
Condition: Alzheimer DiseaseInterventions: Drug: raloxifene; Drug: PlaceboSponsors: Stanford University; Kaiser Permanente; Indiana University; Southern Illinois UniversityCompleted - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2006 Category: Research Source Type: clinical trials
3-year Study of Menostar Versus Evista to Prevent Osteoporosis in Post-menopausal Women
Condition: OsteopeniaInterventions: Drug: Menostar (Estradiol, BAY86-5435); Drug: RaloxifeneSponsor: BayerCompleted - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 31, 2006 Category: Research Source Type: clinical trials
